JP2002284796A - Method for producing lisinopril dihydrate - Google Patents

Method for producing lisinopril dihydrate

Info

Publication number
JP2002284796A
JP2002284796A JP2001086834A JP2001086834A JP2002284796A JP 2002284796 A JP2002284796 A JP 2002284796A JP 2001086834 A JP2001086834 A JP 2001086834A JP 2001086834 A JP2001086834 A JP 2001086834A JP 2002284796 A JP2002284796 A JP 2002284796A
Authority
JP
Japan
Prior art keywords
lisinopril
dihydrate
lizinopril
anhydride
producing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001086834A
Other languages
Japanese (ja)
Inventor
Ryosuke Sasaki
涼介 佐々木
Takahiro Enomoto
貴弘 榎本
Shin Ikeda
伸 池田
Yasuhiro Takahashi
康弘 高橋
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Konica Minolta Chemical Co Ltd
Original Assignee
Konica Minolta Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Konica Minolta Chemical Co Ltd filed Critical Konica Minolta Chemical Co Ltd
Priority to JP2001086834A priority Critical patent/JP2002284796A/en
Publication of JP2002284796A publication Critical patent/JP2002284796A/en
Pending legal-status Critical Current

Links

Landscapes

  • Peptides Or Proteins (AREA)

Abstract

PROBLEM TO BE SOLVED: To provide a method for producing industrially useful lisinopril dihydrate. SOLUTION: The lisinopril dihydrate is obtained in high yield and in high purity by suspension process of lisinopril anhydride in a hydrous alcohol.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【産業上の利用分野】本発明は優れた抗高血圧剤として
知られる、式
BACKGROUND OF THE INVENTION The present invention relates to a compound represented by the formula

【0002】[0002]

【化1】 Embedded image

【0003】で表されるリジノプリル(Nα−((S)−1
−カルボキシ−3−フェニルプロピル)−L−リジル−L−
プロリン)の水和物の製造法に関するものである。
Lisinopril (Nα-((S) -1)
-Carboxy-3-phenylpropyl) -L-lysyl-L-
(Proline).

【0004】[0004]

【従来の技術】リジノプリルは一般的に各構成アミノ酸
を原料として、ペプチド合成で常用される方法によって
合成される。これを必要に応じて精製工程を経て、目的
のリジノプリル2水和物を得る。
2. Description of the Related Art Lisinopril is generally synthesized from each constituent amino acid by a method commonly used in peptide synthesis. This is optionally subjected to a purification step to obtain the target lisinopril dihydrate.

【0005】リジノプリル粗体を有機溶媒で再結晶精製
する場合、目的のリジノプリルは無水物として得られ
る。そのため無水物から水和物へと変換する手段とし
て、調湿された雰囲気下で無水物を吸湿水和物化させる
処理方法もしくは、公開特許公報昭61−36297に
あるように水または含水溶媒から再結晶精製して水和物
化する等の処理方法が知られている。
[0005] When refining and refining a crude product of Lisinopril with an organic solvent, the desired Lisinopril is obtained as an anhydride. Therefore, as a means for converting an anhydride to a hydrate, a treatment method for converting the anhydride into a hygroscopic hydrate in a conditioned atmosphere or a method for re-forming from water or a water-containing solvent as disclosed in JP-A-61-36297. Processing methods such as crystal purification and hydration are known.

【0006】[0006]

【発明が解決しようとする課題】しかしながら前記2つ
の水和物化の方法は、工業的に重大な欠点がある。すな
わち、調湿された雰囲気下で無水物に吸湿水和物化させ
る方法では長い処理時間を必要とし、また無水物の表面
と内部では水和物化の速度に差が有るため得られる水和
物の回収率および処理に要する時間にばらつきがみら
れ、結果的に品質の不安定化を招く。
However, the above two methods of hydration have serious industrial disadvantages. In other words, the method of forming a hydrate into an anhydride under a conditioned atmosphere requires a long treatment time, and there is a difference in the rate of hydration between the surface and the inside of the anhydride. The recovery and the time required for processing vary, resulting in quality instability.

【0007】また、含水溶媒から再結晶精製して水和物
を得る処理では、均一に水和物化されるが、リジノプリ
ルの水に対する溶解性が高い為に得られる水和物の回収
率が低くなり、経済的でない。
In the process of obtaining a hydrate by recrystallization purification from a water-containing solvent, the hydrate is uniformly hydrated. However, since the solubility of lisinopril in water is high, the recovery rate of the obtained hydrate is low. Is not economical.

【0008】また、リジノプリル粗体から直接含水溶媒
を用いて水和物化する場合、一度有機溶媒で再結晶精製
した後含水溶媒で水和物化した場合と比べて精製効果が
低く、得られる水和物は低純度である。そのため、高純
度のリジノプリル水和物を効率よく得るためには新たな
手段が必要であった。
Further, when hydration is performed directly from a crude form of Lisinopril using a water-containing solvent, the purification effect is lower than in the case of recrystallization purification once with an organic solvent and then hydration with a water-containing solvent. The material is of low purity. Therefore, a new means was required to efficiently obtain high-purity lisinopril hydrate.

【0009】[0009]

【課題を解決する為の手段】本発明者らは前記課題の解
決を目的に検討した結果、高い収率で目的とするリジノ
プリル2水和物を得る方法を開発した。すなわち、リジ
ノプリル粗体を有機溶媒から再結晶精製し、次いで含水
アルコール溶媒中で縣濁処理することで収率良く、安定
した品質でリジノプリル2水和物が得られることを見出
した。本発明で用いられるアルコールとしては、C1〜
C4の低級アルコール好ましくはエチルアルコールであ
る。アルコールの含水の割合は1〜20%、好ましくは
5〜15%の範囲から選ばれる。含水量が多すぎると回
収率が低くなり、少ないと水和物化の速度が遅くなる。
以下、実施例により本発明をさらに詳しく説明する。
Means for Solving the Problems The inventors of the present invention have studied for solving the above-mentioned problems, and as a result, have developed a method for obtaining the desired lisinopril dihydrate in a high yield. That is, the present inventors have found that lizinopril dihydrate can be obtained with good yield and stable quality by recrystallizing and purifying a crude product of lizinopril from an organic solvent and then suspending the crude product in a hydroalcoholic solvent. The alcohol used in the present invention includes C1
C4 lower alcohol, preferably ethyl alcohol. The water content of the alcohol is selected from the range of 1 to 20%, preferably 5 to 15%. If the water content is too high, the recovery will be low, and if it is low, the rate of hydration will be slow.
Hereinafter, the present invention will be described in more detail with reference to examples.

【0010】[0010]

【実施例1】リジノプリル無水物の調製 2.4gのリジノプリル粗体を、酢酸エチル4.8ml
とメチルアルコール7.3mlから再結晶精製して2.
1gのリジノプリル無水物を得た(HPLC純度99.
9%)。
Example 1 Preparation of Lizinopril Anhydride 2.4 g of Lizinopril crude was mixed with 4.8 ml of ethyl acetate.
And purified by recrystallization from 7.3 ml of methyl alcohol.
1 g of Lizinopril anhydride was obtained (HPLC purity 99.
9%).

【0011】[0011]

【実施例2】リジノプリル2水和物の調製 1.6gのリジノプリル無水物を、10%含水エチルア
ルコール8ml中室温で2日間攪拌後結晶をろ過して
1.4gのリジノプリル2水和物を得た。得られたリジ
ノプリルの粉末X線回折スペクトル(図1)は、公開特
許公報昭61−36297記載の調製方法で単離したリ
ジノプリル2水和物の粉末X線回折スペクトル(図2)
と一致した。
Example 2 Preparation of Lizinopril dihydrate 1.6 g of Lizinopril anhydride was stirred in 8 ml of 10% aqueous ethyl alcohol at room temperature for 2 days, and the crystals were filtered to obtain 1.4 g of Lizinopril dihydrate. Was. The powder X-ray diffraction spectrum of the obtained lisinopril (FIG. 1) is the same as the powder X-ray diffraction spectrum of lisinopril dihydrate isolated by the preparation method described in JP-A-61-36297 (FIG. 2).
And matched.

【0012】[0012]

【図1】 FIG.

【0013】[0013]

【図2】 FIG. 2

【0014】[0014]

【参考例】リジノプリル2水和物の調製 2.4gのリジノプリル粗体を、10%含水エチルアル
コール16mlから再結晶精製して1.4gのリジノプ
リル2水和物0.52gを得た。(HPLC純度98
%)
Reference Example Preparation of Lizinopril Dihydrate 2.4 g of Lizinopril crude was purified by recrystallization from 16 ml of 10% aqueous ethyl alcohol to obtain 1.4 g of Lizinopril dihydrate 0.52 g. (HPLC purity 98
%)

【0015】[0015]

【発明の効果】本発明の製造法によると、リジノプリル
2水和物を簡便な操作で収率良く高純度で得ることがで
きる。
According to the production method of the present invention, lisinopril dihydrate can be obtained with high yield and high purity by a simple operation.

───────────────────────────────────────────────────── フロントページの続き (72)発明者 高橋 康弘 福島県相馬郡小高町蛯沢字笠谷26 株式会 社コニカケミカル内 Fターム(参考) 4H045 AA20 BA11 EA23  ──────────────────────────────────────────────────続 き Continued on the front page (72) Inventor Yasuhiro Takahashi 26 Kasaya, Ebizawa, Kodaka-cho, Soma-gun, Fukushima F-term in Konica Chemical Co., Ltd. 4H045 AA20 BA11 EA23

Claims (3)

【特許請求の範囲】[Claims] 【請求項1】リジノプリル(Nα−((S)−1−カルボキ
シ−3−フェニルプロピル)−L−リジル−L−プロリン)
の無水物を含水アルコール溶媒中懸濁することを特徴と
するリジノプリル2水和物の製造方法。
1. Lizinopril (Nα-((S) -1-carboxy-3-phenylpropyl) -L-lysyl-L-proline)
A method for producing lisinopril dihydrate, comprising suspending the anhydride of the above in a hydroalcoholic solvent.
【請求項2】用いるアルコールがエチルアルコールであ
る、請求項1記載の方法。
2. The method according to claim 1, wherein the alcohol used is ethyl alcohol.
【請求項3】用いるアルコールの含水量が5〜15%で
ある、請求項1記載の方法。
3. The process according to claim 1, wherein the water content of the alcohol used is between 5 and 15%.
JP2001086834A 2001-03-26 2001-03-26 Method for producing lisinopril dihydrate Pending JP2002284796A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2001086834A JP2002284796A (en) 2001-03-26 2001-03-26 Method for producing lisinopril dihydrate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001086834A JP2002284796A (en) 2001-03-26 2001-03-26 Method for producing lisinopril dihydrate

Publications (1)

Publication Number Publication Date
JP2002284796A true JP2002284796A (en) 2002-10-03

Family

ID=18942154

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001086834A Pending JP2002284796A (en) 2001-03-26 2001-03-26 Method for producing lisinopril dihydrate

Country Status (1)

Country Link
JP (1) JP2002284796A (en)

Similar Documents

Publication Publication Date Title
HU185619B (en) New process for preparing pure clavulanic acid further pharmacologically acceptable salts and esters thereof
JP2023165756A (en) Crystalline dipeptides useful in synthesis of elamipretide
EP0950664B1 (en) Process for producing N-glycyltyrosine
JP2002284796A (en) Method for producing lisinopril dihydrate
WO2007017087A1 (en) Process for the preparation of crystalline perindopril
CA2182258C (en) Sodium enalapril complex and the use thereof to make sodium enalapril
JP3577756B2 (en) Method for selectively producing N-protected glutamic acid γ-derivative
WO2008096373A2 (en) Process for synthesizing highly pure nateglinide polymorphs
JPS6257180B2 (en)
JP4564375B2 (en) Method for producing theanine
JPH027951B2 (en)
JP2526811B2 (en) Phenethylamine derivative and method for producing the same
JPH01290658A (en) Production of sulfonium compound
JP2993983B2 (en) Separation method of barium from water-soluble strontium salt
JPS606958B2 (en) Antibiotic purification method
JP2522034B2 (en) α-Keto acid / amino acid salt compound and method for producing the same
JPH0770125A (en) Production of alkaline earth metal salt of (6r)-n(10)-formyl-5,6,7,8-tetrahydrofolic acid
JP4307594B2 (en) Method for isolating 1- [N2-((S-ethoxycarbonyl) -3-phenylpropyl) -N6-trifluoroacetyl] -L-lysyl-L-proline and isolated product thereof
JP2004203822A (en) Novel intermediate for manufacturing theanine
JPH078855B2 (en) Sulfonium compound
JPWO2003057665A1 (en) Method for producing benzenesulfonamide derivative crystal, novel crystal of intermediate and method for producing the same
WO2006080484A1 (en) Cefcapene pivoxil methanesulfonate
JPH11180948A (en) Production of s-(1,2-dicarboxyethyl)glutathione
JP2856331B2 (en) Method for producing 2,2-diamino-1,1-binaphthyl
JPH06345684A (en) Purification of 3,5-dimethyl benzoic acid

Legal Events

Date Code Title Description
A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20070725